This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Maria Jure-Kunkel, Ph.D.
Head of Late Stage Oncology Translational Medicine at Genmab


Maria Jure-Kunkel is currently the Head of Late Stage Translational Research at Genmab. Prior to that, she led Translational Medicine and Discovery/Translational Research teams at MedImmune/AstraZeneca and at Bristol-Myers Squibb. In her 20+ years of pharmaceutical experience, Maria has been the recipient of several patents in the field of Immuno-Oncology and had the privilege to contribute to the development of several IO agents including urelumab, ipilimumab and nivolumab.

Agenda Sessions

  • DuoBody®-PD-L1x4-1BB [GEN1046]: Next Generation Checkpoint Immunotherapy Combining PD-1/PD-L1 Blockade with Conditional 4-1BB T-cell Activation

    On Demand
  • Transforming Therapeutic Targets